Insulet Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
44,974.00
51,500.00
85,438.00
30,548.00
26,831.00
3,292
Depreciation, Depletion & Amortization
11,806.00
12,223.00
15,838.00
13,833.00
13,854.00
15,646
Other Funds
3,265.00
8,665.00
2,646.00
2,866.00
4,054.00
69,784
Funds from Operations
3,177.00
19,952.00
20,556.00
29,494.00
39,592.00
88,722
Changes in Working Capital
6,525.00
11,032.00
8,004.00
13,583.00
1,615.00
52,823
Net Operating Cash Flow
3,348.00
8,920.00
12,552.00
15,911.00
41,207.00
35,899
Capital Expenditures
7,307.00
11,486.00
10,608.00
22,115.00
77,226.00
Sale of Fixed Assets & Businesses
-
-
-
5,714.00
-
Purchase/Sale of Investments
-
-
-
161,609.00
133,571.00
Net Investing Cash Flow
7,307.00
11,486.00
15,323.00
178,010.00
210,797.00
Issuance/Reduction of Debt, Net
2,994.00
1,111.00
5,576.00
174,579.00
292,797.00
Net Financing Cash Flow
96,393.00
4,032.00
371.00
176,567.00
304,547.00
Net Change in Cash
92,434.00
1,466.00
28,521.00
14,502.00
135,403.00
Free Cash Flow
3,959.00
2,566.00
23,160.00
6,204.00
36,019.00
Net Assets from Acquisitions
-
-
4,715.00
-
-
Change in Capital Stock
102,652.00
11,586.00
7,851.00
4,854.00
15,804.00
Exchange Rate Effect
-
-
275.00
34.00
446.00

About Insulet

View Profile
Address
100 Nagog Park
Acton Massachusetts 01720
United States
Employees -
Website http://www.myomnipod.com
Updated 07/08/2019
Insulet Corp. is an innovative medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L.